Immunomodulators for Non-Melanoma Skin Cancers: Updated Perspectives. [Review] (Record no. 12573)

MARC details
000 -LEADER
fixed length control field 02506nam a22003857a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 230626s20232023 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1178-7015
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.2147/CCID.S362171 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 362171 [pii]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code PMC10122480 [pmc]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 37095898
245 ## - TITLE STATEMENT
Title Immunomodulators for Non-Melanoma Skin Cancers: Updated Perspectives. [Review]
251 ## - Source
Source Clinical, Cosmetic and Investigational Dermatology CCID. 16:1025-1045, 2023.
252 ## - Abbreviated Source
Abbreviated source Clin Cosmet Investig Dermatol. 16:1025-1045, 2023.
253 ## - Journal Name
Journal name Clinical, cosmetic and investigational dermatology
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2023
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2023
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Publication date 2023
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status epublish
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Medline status PubMed-not-MEDLINE
266 ## - Date added to catalog
Date added to catalog 2023-06-26
520 ## - SUMMARY, ETC.
Abstract Non-melanoma skin cancers (NMSCs) are the most common cancers worldwide and may be associated with significant morbidity and mortality, especially in immunosuppressed populations. Successful management of NMSC must take primary, secondary and tertiary prevention strategies into consideration. In response to an improved understanding of the pathophysiology of NMSC and associated risk factors, multiple systemic and topical immunomodulatory drugs have been developed and integrated into clinical practice. Many of these drugs are efficacious in the prevention and treatment of precursor lesions (actinic keratoses; AKs), low-risk NMSC, and advanced disease. The identification of patients at high risk for the development of NMSC is critical in reducing disease morbidity. Understanding the various treatment options available and their comparative effectiveness is paramount for developing a personalized treatment regimen for such patients. This review article provides an updated overview of the various topical and systemic immunomodulatory drugs available for the prevention and treatment of NMSC, and the published data supporting their use in clinical practice. Copyright © 2023 Russomanno et al.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Indexing Automated
656 ## - INDEX TERM--OCCUPATION
Department Dermatology
656 ## - INDEX TERM--OCCUPATION
Department MedStar Outpatient Care
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
657 ## - INDEX TERM--FUNCTION
Medline publication type Review
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Russomanno, Kristen L
Institution Code MOUT
790 ## - Authors
All authors Russomanno K, Abdel Azim S, Patel VA
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.2147/CCID.S362171">https://dx.doi.org/10.2147/CCID.S362171</a>
Public note https://dx.doi.org/10.2147/CCID.S362171
858 ## - ORCID
Name https://orcid.org/0000-0003-1257-6405
ORCID text Russomanno, Kristen
Orcid <a href="https://orcid.org/0000-0003-1257-6405">https://orcid.org/0000-0003-1257-6405</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 06/26/2023   37095898 37095898 06/26/2023 06/26/2023 Journal Article

Powered by Koha